Lexidronam is a phosphonate analog of ethylenediaminetetraacetic acid (EDTA) with chelating activity. It binds to hydroxyapatite crystals in areas of bone turnover and has been used as a radiopharmaceutical in complexes with radioactive metals to selectively target osteoblastic bone metastases.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Lexidronam?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Diethylenetriamine pentamethylene phosphonic acid
Industrial chelating agent
Aminotris(methylenephosphonic acid)
chelating agent
(((2-hydroxyethyl)imino)dimethylene)diphosphonic acid
chelating agent in industrial applications
1-decanethiol
chemical intermediate and research reagent
1-bromododecane
Alkylating agent for lipophilicity modification
Triethylene glycol monobutyl ether
Solvent, plasticizer, and metal degreasing agent
Tetraglyme
Solvent and lubricating agent
Lexidronam pentasodium
pharmaceutical raw material
The international HS code for Lexidronam (CAS 1429-50-1) is 2931.49.
2931.49
2931 49 40
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[2-[bis(phosphonomethyl)amino]ethyl-(phosphonomethyl)amino]methylphosphonic acid
NFDRPXJGHKJRLJ-UHFFFAOYSA-N
C(CN(CP(=O)(O)O)CP(=O)(O)O)N(CP(=O)(O)O)CP(=O)(O)O
Sourcing Lexidronam?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.